Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia
IrelandStudy on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older
IrelandStudy Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer
IrelandStudy of Epoetin Alfa for Critically Ill Patients with Traumatic Injury
IrelandStudy on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases
IrelandStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery
IrelandStudy Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations
IrelandStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
IrelandStudy on Early Sedation with Dexmedetomidine vs. Placebo for Older Critically Ill Patients on Ventilators
IrelandStudy on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
IrelandStudy of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
IrelandStudy on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
